488 related articles for article (PubMed ID: 21172868)
21. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells.
Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T
Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537
[TBL] [Abstract][Full Text] [Related]
22. IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance.
Schulz SM; Köhler G; Holscher C; Iwakura Y; Alber G
Int Immunol; 2008 Sep; 20(9):1129-38. PubMed ID: 18599501
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
24. CCR6 is required for epidermal trafficking of γδ-T cells in an IL-23-induced model of psoriasiform dermatitis.
Mabuchi T; Singh TP; Takekoshi T; Jia GF; Wu X; Kao MC; Weiss I; Farber JM; Hwang ST
J Invest Dermatol; 2013 Jan; 133(1):164-71. PubMed ID: 22895364
[TBL] [Abstract][Full Text] [Related]
25. Periostin contributes to epidermal hyperplasia in psoriasis common to atopic dermatitis.
Arima K; Ohta S; Takagi A; Shiraishi H; Masuoka M; Ontsuka K; Suto H; Suzuki S; Yamamoto K; Ogawa M; Simmons O; Yamaguchi Y; Toda S; Aihara M; Conway SJ; Ikeda S; Izuhara K
Allergol Int; 2015 Jan; 64(1):41-8. PubMed ID: 25572557
[TBL] [Abstract][Full Text] [Related]
26. Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia.
Shimoura N; Nagai H; Fujiwara S; Jimbo H; Yoshimoto T; Nishigori C
Arch Dermatol Res; 2017 May; 309(4):315-321. PubMed ID: 28299442
[TBL] [Abstract][Full Text] [Related]
27. Recombinant murine interleukin 4 protein therapy for psoriasis in a transgenic VEGF mouse model.
Ren X; Li J; Zhou X; Luo X; Huang N; Wang Y; Chen X; Wei Y
Dermatology; 2009; 219(3):232-8. PubMed ID: 19729876
[TBL] [Abstract][Full Text] [Related]
28. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
Miyazaki Y; Hamano S; Wang S; Shimanoe Y; Iwakura Y; Yoshida H
J Immunol; 2010 Jul; 185(2):1150-7. PubMed ID: 20562260
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
30. Cathepsin K is involved in development of psoriasis-like skin lesions through TLR-dependent Th17 activation.
Hirai T; Kanda T; Sato K; Takaishi M; Nakajima K; Yamamoto M; Kamijima R; Digiovanni J; Sano S
J Immunol; 2013 May; 190(9):4805-11. PubMed ID: 23543761
[TBL] [Abstract][Full Text] [Related]
31. IL-17 in cutaneous lupus erythematosus.
Tanasescu C; Balanescu E; Balanescu P; Olteanu R; Badea C; Grancea C; Vagu C; Bleotu C; Ardeleanu C; Georgescu A
Eur J Intern Med; 2010 Jun; 21(3):202-7. PubMed ID: 20493423
[TBL] [Abstract][Full Text] [Related]
32. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis.
Jiang W; Zhu FG; Bhagat L; Yu D; Tang JX; Kandimalla ER; La Monica N; Agrawal S
J Invest Dermatol; 2013 Jul; 133(7):1777-84. PubMed ID: 23370539
[TBL] [Abstract][Full Text] [Related]
33. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice.
Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y
J Immunol; 2010 Aug; 185(3):1887-93. PubMed ID: 20610641
[TBL] [Abstract][Full Text] [Related]
34. The role of IL-17 in psoriasis.
Malakouti M; Brown GE; Wang E; Koo J; Levin EC
J Dermatolog Treat; 2015 Feb; 26(1):41-4. PubMed ID: 24552504
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-1 alpha mediates phorbol ester-induced inflammation and epidermal hyperplasia.
Lee WY; Lockniskar MF; Fischer SM
FASEB J; 1994 Oct; 8(13):1081-7. PubMed ID: 7926375
[TBL] [Abstract][Full Text] [Related]
36. Galectin-8 Is Upregulated in Keratinocytes by IL-17A and Promotes Proliferation by Regulating Mitosis in Psoriasis.
Lo YH; Li CS; Chen HL; Chiang CY; Huang CC; Tu TJ; Lo TH; Choy DF; Arron JR; Chen HY; Liu FT
J Invest Dermatol; 2021 Mar; 141(3):503-511.e9. PubMed ID: 32805218
[TBL] [Abstract][Full Text] [Related]
37. Role of IL-17A in the development of colitis-associated cancer.
Hyun YS; Han DS; Lee AR; Eun CS; Youn J; Kim HY
Carcinogenesis; 2012 Apr; 33(4):931-6. PubMed ID: 22354874
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease.
Karbach S; Croxford AL; Oelze M; Schüler R; Minwegen D; Wegner J; Koukes L; Yogev N; Nikolaev A; Reißig S; Ullmann A; Knorr M; Waldner M; Neurath MF; Li H; Wu Z; Brochhausen C; Scheller J; Rose-John S; Piotrowski C; Bechmann I; Radsak M; Wild P; Daiber A; von Stebut E; Wenzel P; Waisman A; Münzel T
Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2658-68. PubMed ID: 25341795
[TBL] [Abstract][Full Text] [Related]
39. ACT1 Is Required for Murine IL-23-Induced Psoriasiform Inflammation Potentially Independent of E3 Ligase Activity.
Lipovsky A; Slivka PF; Su Z; Wang Y; Paulsboe S; Wetter J; Namovic MT; Gauvin D; Perron D; Gauld SB; McGaraughty S; Goedken ER
J Invest Dermatol; 2021 Jul; 141(7):1772-1779.e6. PubMed ID: 33548244
[TBL] [Abstract][Full Text] [Related]
40. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W
J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]